The Only Path to Precision Medicine: Millions of Genomes and AI

The Only Path to Precision Medicine: Millions of Genomes and AI

The Only Path to Precision Medicine: Millions of Genomes and AI
We hope that you enjoyed hearing from industry leaders about how they are working to expedite therapy development, incorporate digital therapeutics at scale, and improve patient outcomes. For more information on other ways AWS can help your healthcare and life sciences organization, visit us at: https://amzn.to/2XEbYGf or contact the team at: [email protected]

Mission Bio delivers targeted solutions for high impact single-cell applications with the Tapestri Platform, the industry’s first single-cell DNA sequencing solution. Enabling precise detection of heterogeneity in disease progression and treatment response, Tapestri applications include blood cancers, solid tumors, and genome editing validation. The Tapestri Platform includes an instrument, consumables and software, and is bookended by machine learning, improving assay quality and cost at the front end, and increasing the predictive power of single-cell data at the back end. Honored as a Top 10 Innovation of 2018 by The Scientist, the Tapestri Platform was also recently adopted by LabCorp. (missionbio.com)

View on YouTube

Sharing is caring!

Comments are closed.